BiotechTube
Home/Syros Pharmaceuticals/Keith A. Katkin
KA

Keith A. Katkin

Board Member

Syros Pharmaceuticals

Roles

Board MemberatSyros Pharmaceuticals
Chairman of the BoardatSyndax Pharmaceuticals

Therapeutic Areas

Oncology

Syros Pharmaceuticals Pipeline

DrugIndicationPhase
Tamibarotene (SY-1425)RARA-positive Higher-Risk MDSPhase 3
SY-2101Acute Promyelocytic Leukemia (APL)Phase 3
SY-5609Solid TumorsPhase 1/2
SY-5007RET-altered Solid TumorsPreclinical

Leadership Team at Syros Pharmaceuticals

CC
Conley Chee
Chief Executive Officer
DA
David A. Roth
Chief Medical Officer
JH
Jason Haas
Chief Financial Officer
ER
Eric R. Olson
Chief Scientific Officer, Co-founder
MK
Marcin Kortylewski
Board Member
NS
Nancy Simonian
Former Chief Executive Officer
View full Syros Pharmaceuticals profile